Does the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?

MTHFR A1298C (rs1801131; Glu429Ala) is a common functional variant whose metabolic consequences are generally modest. For a 52-year-old man, its presence alone does not establish clinically important hyperhomocysteinemia; measured fasting total homocysteine and nutritional status are more informative than genotype alone.

Functional and clinical evidence

• A1298C can mildly reduce MTHFR function. Recombinant 1298C enzyme activity was approximately 68% of wild type; genotype-based lymphocyte measurements found residual activity around 61% in CC carriers versus ~66% in AA/AC groups.
• Its association with fasting or plasma homocysteine is small, context-dependent, and often not independently detectable after adjustment.
• By contrast, C677T—especially TT homozygosity—is the strongest MTHFR genetic predictor of higher homocysteine in adjusted fasting-cohort data. Thus, the claim that A1298C’s homocysteine effect is usually smaller and less consistent than C677T’s is well aligned with the overall evidence, although the exact comparative magnitude varies across populations and folate environments.

Mechanistic interpretation

• MTHFR converts 5,10-methylene-THF to 5-methyltetrahydrofolate (5-MTHF). 5-MTHF supplies the methyl group for vitamin B12-dependent methionine synthase, which remethylates homocysteine to methionine.
• A1298C affects the C-terminal regulatory region and produces a modest activity decrement without the prominent heat-sensitive phenotype of C677T.
• C677T (Ala222Val) more substantially impairs function through FAD destabilization, thermolability, and reduced residual activity, particularly in TT carriers, providing a biologically coherent explanation for its stronger homocysteine association.

Clinical context

• Folate availability materially modifies genotype effects: homocysteine differences are more apparent with low folate and may be attenuated in folate-fortified settings.

Bottom line

• A1298C can mildly reduce MTHFR activity, but its independent effect on homocysteine is usually limited and less reproducible than C677T’s; clinical interpretation should prioritize actual homocysteine and folate/B-vitamin status over A1298C genotype alone.